U.N. health officials have estimated that more than 14 million children did not receive a single vaccine last year.

Kenya has been selected as one of the 9 early adopter countries for the rollout of Lenacapavir (LEN), a long-acting ...

The World Health Organization on Monday recommended Gilead's lenacapavir, a twice-yearly injection, as a tool to prevent HIV ...

LEN is the first long-acting PrEP product that requires only two injections per year, offering an appealing alternative to ...

The World Health Organization (WHO) has recommended the global use of injectable lenacapavir (LEN) twice a year to provide near-total ...

As expected, the new recommendations that the World Health Organization (WHO) issued for HIV and sexually transmitted ...

The World Health Organization (WHO) and UNICEF have raised the alarm over widening immunization gaps globally, warning that millions of ...

A breakthrough HIV drug that only needs to be injected twice a year to offer near-total protection from the virus and ...

An estimated 14.3 million children globally remain unvaccinated and vulnerable to vaccine-preventable illnesses – meaning ...

The World Health Organization now recommends lenacapavir, a twice-yearly injectable HIV prevention drug, especially for high-risk groups. This endorse ...

The 78th World Health Assembly in Geneva this May marked a turning point in global health diplomacy. For the first time since ...

The World Health Organization (WHO) has officially recommended the global rollout of injectable lenacapavir (LEN), a ...